Printer Friendly 14,709,465 articles and books

Periodicals Literature Keyword Title Author Topic

Member login User name    Password    Remember me Join us Forgot password?

Submit articles free

Browse Metastasis topic

Drug therapy subtopic

Articles 1-67 out of 67 article(s) Title Author Type Date Words United States : FDA Grants Additional Fast Track Designation for OGX-011 in Combination with First Line Chemotherapy. Oct 9, 2009 269 PCF Funding for Bone Metastasis Research Supports New Drug to Improve Lives of Prostate Cancer Patients. Aug 20, 2009 1029 SHORT-COURSE RADIOTHERAPY EFFECTIVE FOR BONE METASTASES. Jul 1, 2009 621 ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec. Jun 29, 2009 949 New Data Suggest Treatment Regimens That Include ABRAXANE[R] May Be Active in Treating Metastatic Melanoma. Jun 1, 2009 2007 Study Explores Potential Benefit of Nab[R]-Paclitaxel in Combination with Bevacizumab for the First-Line Treatment of Metastatic Breast Cancer. Jun 1, 2009 1567 New Data Demonstrate Anti-Tumor Activity for ABRAXANE[R] Combination Chemotherapy Regimen in Patients with Metastatic Pancreatic Cancer. Clinical report May 31, 2009 1436 Drug boost for kidney cancer patients. May 18, 2009 182 Triple drug therapy shows promise in treating breast cancer. May 16, 2009 287 Sirtex Announces its Support of The Liver Symposium - Unique Meeting of Patients and Medical Practitioners to Examine Advances in Treatment, Challenges of Liver Cancer. May 6, 2009 725 Novel drug shows promise in treating drug-resistant prostate cancer. Apr 11, 2009 247 Novel drug shows promise in treating drug-resistant prostate cancer. Apr 9, 2009 247 Novel drug shows promise in treating drug-resistant prostate cancer. Apr 8, 2009 247 AngioChem's ANG1005 Shows Promise In the Treatment of Brain Cancers. Mar 19, 2009 786 Cell Genesys Announces Final Results from Phase 3 Program of GVAX Immunotherapy for Prostate Cancer. Financial report Feb 27, 2009 1220 Cancer drug hope. Dec 15, 2008 84 Levoleucovorin (FUSILEV[TM]) Listed in the NCCN Drugs & Biologics Compendium[TM] and NCCN Updates Clinical Practice Guidelines in Oncology[TM]. Dec 11, 2008 1038 Popular cancer drug 'increases blood clot risk'. Dec 3, 2008 458 Popular cancer drug 'increases blood clot risk'. Nov 25, 2008 458 Bostwick Therapeutics Announces Initiation of Novel Phase I/II Personalized Medicine Immunotherapy Trial for Advanced Prostate Cancer. Sep 5, 2008 457 HANA BIOSCIENCES GETS U.S.ORPHAN DRUG DESIGNATION FOR MARQIBO. Aug 1, 2008 664 Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer. Jul 18, 2008 1628 Molecular Insight Pharmaceuticals, Inc. Reports Preclinical Data on Solazed(TM) for Treatment of Metastatic Melanoma at Society of Nuclear Medicine (SNM) Meeting. Jun 16, 2008 887 Combination Therapy of Solvent-Free ABRAXANE(R) and the Targeted Therapy Bevacizumab Evaluated as First-Line Treatment for Metastatic Breast Cancer. Jun 2, 2008 1469 Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases. May 27, 2008 1062 Sirtex Launches Global Clinical Trial Comparing the Use of SIR-Spheres(R) Microspheres Plus Chemotherapy versus Chemotherapy Alone as First Line Treatment for Metastatic Colorectal Cancer. Clinical report May 21, 2008 600 Spectrum Pharmaceuticals Presents Data on Lucanthone, a Novel Anticancer Drug, at the Meeting of the American Association of Cancer Research. Apr 17, 2008 1121 Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea. Apr 9, 2008 1252 Avastin's Use in Treatment of Metastatic Breast Cancer Expected to Increase Dramatically on Heels of FDA's Accelerated Approval, According to Study by GfK Market Measures. Mar 10, 2008 622 Individualising treatment options for patients. Kohne, Claus-Henning Mar 1, 2008 499 Gemcitabine and cisplatin in patients with locally advanced, recurrent, or metastatic head and neck cancer: results of a Phase II trial. Kyasa, Mouhammed J.; Breau, Randall L.; Hanna, Ehab; Suen, James; Maddox, Anne-Marie Mar 1, 2008 2464 Biothera Drug Synergistic with Avastin(R) Against Cancer, Study Finds. Feb 28, 2008 497 FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer. Feb 22, 2008 1401 Synta and GlaxoSmithKline Announce Elesclomol Granted Orphan Drug Designation by the FDA. Jan 28, 2008 1060 The Angeles Clinic and Research Institute Initiates Global Phase 3 Clinical Trial for New Melanoma Drug. Jan 7, 2008 759 Data Presented at the 30th San Antonio Breast Cancer Symposium Supports Further Development of INCB7839 as a New Oral Treatment for Breast Cancer. Dec 16, 2007 1295 Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer. Dec 5, 2007 1467 NCCN Receives Major Grant for Anti-Cancer Drug Study. Report Nov 15, 2007 634 Abraxis BioScience Receives a Positive Opinion in Europe from the CHMP for the Approval of ABRAXANE for the Treatment of Metastatic Breast Cancer. Oct 18, 2007 764 CoFactor, Adventrx Pharmaceuticals' cancer drug candidate, fails trial. Chambers, Heather Oct 8, 2007 322 Adventtrx cancer drug candidate gets FDA fast-track OK. Chambers, Heather Aug 27, 2007 189 GammaCan Receives FDA Orphan Drug Designation for Lead Product VitiGam(TM) for Stage IIB to Stage IV Melanoma. Aug 7, 2007 1016 Light Sciences Oncology Initiates Phase III Trial of Its Light Infusion Therapy (Litx(TM)) in Patients with Metastatic Colorectal Cancer. Jul 17, 2007 709 SRI International Cancer Drug SR16388 Selected by the National Cancer Institute as Promising Treatment for Advanced Prostate Cancer. Jun 20, 2007 600 Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug. Jun 1, 2007 691 Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer. Clinical report Apr 10, 2007 2232 MultiCell Technologies Announces Prospective Cancer Treatment Drug. Feb 15, 2007 829 Combination of Introgen's Nanoparticles Demonstrate Increased Efficacy in the Treatment of Metastatic Lung Cancer. Disease/Disorder overview Jan 16, 2007 709 Bacteria-based immune therapy targets liver metastases. Brief article Jan 1, 2007 255 Interim Data from a Randomized, Head-to-Head Phase II Study Shows Weekly ABRAXANE Increased Tumor Response Rate by Greater Than 60 Percent versus Taxotere in First-Line Treatment of Metastatic Breast Cancer. Disease/Disorder overview Dec 17, 2006 1737 Synta Pharmaceuticals Announces FDA Fast Track Designation for STA-4783 in Metastatic Melanoma. Nov 15, 2006 981 Avantogen Oncology Inc. Announces FDA Acceptance Of Its IND For The Novel Cancer Drug Candidate, RP101. Clinical report Oct 30, 2006 415 FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer. Sep 27, 2006 1585 OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer. Sep 21, 2006 1163 Argos Therapeutics Initiates Phase I/II Trial with AGS-003 Personalized Immunotherapy in Advanced Kidney Cancer; Trial to Evaluate New Production Process That May Yield More Potent Immune Response. Aug 17, 2006 683 Pro-Pharmaceuticals Files Phase II Clinical Trial Protocol for First Line Treatment of Colorectal Cancer Patients; Regimen Includes DAVANAT(R) with Avastin(R), 5-FU & Leucovorin. Jul 25, 2006 965 How wonder drug works to combat a common killer. Jun 23, 2006 112 Drug review. Jun 19, 2006 139 Approval for lung drugs. Jun 13, 2006 169 Amgen and Abgenix Complete Biologics License Application for FDA Approval of Panitumumab. Mar 30, 2006 1865 GammaCan Announces Positive Pre-IND Meeting with the U.S. FDA Regarding VitiGam - the Company's Novel Treatment for Metastatic Malignant Melanoma. Mar 22, 2006 739 Erimos Pharmaceuticals Announces Phase I Study of EM-1421 Initiated at Three U.S. Sites; Intravenous formulation to target tumors unresponsive to conventional therapy. Jan 24, 2006 458 FDA Approves Tarceva(R) in Combination with Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer; Tarceva Now Approved for Advanced Non-Small Cell Lung Cancer and Pancreatic Cancer. Nov 2, 2005 1715 FDA Accepts ERBITUX(R) (Cetuximab) sBLA Submission for the Treatment of Squamous Cell Carcinoma of the Head and Neck and Grants Priority Review. Oct 31, 2005 1388 Sonus starts key cancer drug trial. Sep 29, 2005 477 The Ac-PHSCN-NH2 Peptide as a Potent Anti-Tumorigenic and Anti-Metastatic Agent for Prostate Cancer. Aug 1, 2000 3127 Breast cancer drug shows promise for other cancers. Jan 1, 1997 431

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles